Nixon Peabody
Bank of America
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Alzheimer’s drug news boosts Amgen, Inogen

By   /   Friday, July 13th, 2018  /   Comments Off on Alzheimer’s drug news boosts Amgen, Inogen

    Print       Email
Stock prices for tri-county biotech companies have spiked since an announcement July 6 that an Alzheimer’s drug developed by Biogen showed positive results in a large clinical trial, raising hopes for treatment of a disease that has befuddled researchers for decades. Thousand Oaks-based Amgen climbed as high as $196.15 and was up $5.78 per share…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Developer plans to add 1,270 homes to the Nipomo region

Read More →